Filing Flows › Neogen (NEOG) › R&D spending
Neogen (NEOG) R&D spending by quarter
Neogen's R&D spending was $6.5M in Q1 FY27 (first quarter fiscal 2027), +33% from Q4 FY26. Over the last 7 quarters it ranged from $3.8M (Q3 FY26) to $6.5M (Q1 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $6.5M | +33% | +27% |
| Q4 FY26 | $4.9M | +29% | -22% |
| Q3 FY26 | $3.8M | -17% | -16% |
| Q2 FY26 | $4.6M | -11% | — |
| Q1 FY26 | $5.1M | -19% | — |
| Q4 FY25 | $6.3M | +40% | — |
| Q3 FY25 | $4.5M | — | — |
Q1 FY27 at a glance
Neogen, Q1 FY27: revenue $223M (+6% year over year), operating margin -0.8%, net loss $11.9M, operating cash flow $12.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Neogen's R&D spending?
Neogen's R&D spending was $6.5M in Q1 FY27 (first quarter fiscal 2027), +33% from Q4 FY26.
How has Neogen's R&D spending changed?
Over the last 7 quarters it ranged from $3.8M (Q3 FY26) to $6.5M (Q1 FY27).